|
BDP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.435620E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.376700E-03 |
| Normal-vs-Stage2 |
8.661600E-02 |
| Normal-vs-Stage3 |
3.999800E-01 |
| Normal-vs-Stage4 |
5.902600E-01 |
| Stage1-vs-Stage2 |
9.039600E-01 |
| Stage1-vs-Stage3 |
4.760200E-02 |
| Stage1-vs-Stage4 |
1.850250E-02 |
| Stage2-vs-Stage3 |
2.234600E-01 |
| Stage2-vs-Stage4 |
1.667960E-01 |
| Stage3-vs-Stage4 |
7.830800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.667720E-02 |
| Normal-vs-AfricanAmerican |
2.422600E-01 |
| Normal-vs-Asian |
5.483800E-02 |
| Caucasian-vs-AfricanAmerican |
6.364400E-01 |
| Caucasian-vs-Asian |
4.318800E-01 |
| AfricanAmerican-vs-Asian |
2.760400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.848100E-02 |
| Normal-vs-Female |
1.439760E-02 |
| Male-vs-Female |
4.318800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.843200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.496500E-03 |
| Normal-vs-Age(61-80Yrs) |
4.043500E-02 |
| Normal-vs-Age(81-100Yrs) |
7.556200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.415200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.476400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.991600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.155200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.338400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.652600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.218300E-03 |
| Normal-vs-Grade 2 |
1.409620E-04 |
| Normal-vs-Grade 3 |
3.682600E-01 |
| Normal-vs-Grade 4 |
3.239400E-01 |
| Grade 1-vs-Grade 2 |
5.526600E-01 |
| Grade 1-vs-Grade 3 |
1.692050E-02 |
| Grade 1-vs-Grade 4 |
9.781600E-04 |
| Grade 2-vs-Grade 3 |
5.003700E-04 |
| Grade 2-vs-Grade 4 |
1.55440000004781E-06 |
| Grade 3-vs-Grade 4 |
4.632200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.52730000000578E-05 |
| Normal-vs-ccB subtype |
6.786200E-01 |
| ccA subtype-vs-ccB subtype |
3.74269999999788E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.361700E-02 |
| Normal-vs-N1 |
6.765400E-01 |
| N0-vs-N1 |
2.401000E-01 |
|
|
